Literature DB >> 21357516

Role of intrarenal angiotensin system activation, oxidative stress, inflammation, and impaired nuclear factor-erythroid-2-related factor 2 activity in the progression of focal glomerulosclerosis.

Hyun Ju Kim1, Tadashi Sato, Bernardo Rodríguez-Iturbe, Nosratola D Vaziri.   

Abstract

The Imai rat is a model of spontaneous focal glomerulosclerosis, which leads to heavy proteinuria, hyperlipidemia, hypertension, and progressive renal failure. Treatment with AT1 blockers (ARBs) ameliorates proteinuria, hyperlipidemia, and nephropathy in this model. Progression of renal disease in 5/6 nephrectomized rats is associated with activation of the intrarenal angiotensin system, up-regulation of the oxidative, inflammatory, and fibrogenic pathways, and impaired activity of nuclear factor-erythroid-2-related factor 2 (Nrf2), the master regulator of genes encoding antioxidant molecules. We hypothesized that progressive nephropathy in the Imai rat is accompanied by oxidative stress, inflammation, and impaired Nrf2 activation and that amelioration of nephropathy with AT1 receptor blockade in this model may be associated with the reversal of these abnormalities. Ten-week-old Imai rats were randomized to the ARB-treated (olmesartan, 10 mg/kg/day for 24 weeks) or vehicle-treated groups. Sprague-Dawley rats served as controls. At 34 weeks of age Imai rats showed heavy proteinuria, hypoalbuminemia, hypertension, azotemia, glomerulosclerosis, tubulointerstitial inflammation, increased angiotensin II expressing cell population, up-regulations of AT1 receptor, AT2 receptor, NAD(P)H oxidase, and inflammatory mediators, activation of nuclear factor-κB and reduction of Nrf2 activity and expression of its downstream gene products in the renal cortex. ARB therapy prevented nephropathy, suppressed oxidative stress and inflammation, and restored Nrf2 activation and expression of the antioxidant enzymes. Thus progressive focal glomerulosclerosis in the Imai rats is associated with oxidative stress, inflammation, and impaired Nrf2 activation. These abnormalities are accompanied by activation of intrarenal angiotensin system and can be prevented by ARB administration.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21357516     DOI: 10.1124/jpet.110.175828

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  38 in total

1.  Role of Nrf2 dysfunction in uremia-associated intestinal inflammation and epithelial barrier disruption.

Authors:  Wei Ling Lau; Shu-Man Liu; Sogol Pahlevan; Jun Yuan; Mahyar Khazaeli; Zhenmin Ni; Jefferson Y Chan; Nosratola D Vaziri
Journal:  Dig Dis Sci       Date:  2014-11-16       Impact factor: 3.199

2.  LCZ696 (Sacubitril/valsartan) ameliorates oxidative stress, inflammation, fibrosis and improves renal function beyond angiotensin receptor blockade in CKD.

Authors:  Wanghui Jing; Nosratola D Vaziri; Ane Nunes; Yasunori Suematsu; Ted Farzaneh; Mahyar Khazaeli; Hamid Moradi
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

Review 3.  Oxidant Mechanisms in Renal Injury and Disease.

Authors:  Brian B Ratliff; Wasan Abdulmahdi; Rahul Pawar; Michael S Wolin
Journal:  Antioxid Redox Signal       Date:  2016-04-26       Impact factor: 8.401

4.  Angiotensin II induces nephrin dephosphorylation and podocyte injury: role of caveolin-1.

Authors:  Zhilong Ren; Wei Liang; Cheng Chen; Hongxia Yang; Pravin C Singhal; Guohua Ding
Journal:  Cell Signal       Date:  2011-10-01       Impact factor: 4.315

Review 5.  African Americans, hypertension and the renin angiotensin system.

Authors:  Sandra F Williams; Susanne B Nicholas; Nosratola D Vaziri; Keith C Norris
Journal:  World J Cardiol       Date:  2014-09-26

6.  Uremia induces upregulation of cerebral tissue oxidative/inflammatory cascade, down-regulation of Nrf2 pathway and disruption of blood brain barrier.

Authors:  Wanghui Jing; Bahman Jabbari; Nosratola D Vaziri
Journal:  Am J Transl Res       Date:  2018-07-15       Impact factor: 4.060

7.  Systemic inflammation and oxidative stress in hemodialysis patients are associated with down-regulation of Nrf2.

Authors:  Liliana M Pedruzzi; Ludmila F M F Cardozo; Julio B Daleprane; Milena B Stockler-Pinto; Elisa B Monteiro; Maurilo Leite; Nosratola D Vaziri; Denise Mafra
Journal:  J Nephrol       Date:  2015-01-14       Impact factor: 3.902

8.  A 4.1-Mb congenic region of Rf-4 contributes to glomerular permeability.

Authors:  Caitlin C O'Meara; Michelle M Lutz; Allison B Sarkis; Haiyan Xu; Rajendra K Kothinti; Matthew Hoffman; Carol Moreno; Niloofar M Tabatabai; Jozef Lazar; Richard J Roman; Howard J Jacob
Journal:  J Am Soc Nephrol       Date:  2012-02-16       Impact factor: 10.121

9.  Resveratrol prevents renal lipotoxicity in high-fat diet-treated mouse model through regulating PPAR-α pathway.

Authors:  Yan Zhou; Suxian Lin; Lihe Zhang; Yongji Li
Journal:  Mol Cell Biochem       Date:  2015-09-30       Impact factor: 3.396

10.  NRF2 and NF-κB mRNA expression in chronic kidney disease: a focus on nondialysis patients.

Authors:  Viviane O Leal; Juliana F Saldanha; Milena B Stockler-Pinto; Ludmila F M F Cardozo; Felipe R Santos; Alex S D Albuquerque; Maurilo Leite; Denise Mafra
Journal:  Int Urol Nephrol       Date:  2015-10-22       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.